BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 12547248)

  • 21. GRP75 overexpression rescues frataxin deficiency and mitochondrial phenotypes in Friedreich ataxia cellular models.
    Dong YN; McMillan E; Clark EM; Lin H; Lynch DR
    Hum Mol Genet; 2019 May; 28(10):1594-1607. PubMed ID: 30590615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular genetics and pathogenesis of Friedreich ataxia.
    Pandolfo M
    Neuromuscul Disord; 1998 Aug; 8(6):409-15. PubMed ID: 9713860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iron dysregulation in Friedreich ataxia.
    Wilson RB
    Semin Pediatr Neurol; 2006 Sep; 13(3):166-75. PubMed ID: 17101455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Friedreich ataxia: an update on animal models, frataxin function and therapies.
    González-Cabo P; Llorens JV; Palau F; Moltó MD
    Adv Exp Med Biol; 2009; 652():247-61. PubMed ID: 20225031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic developments in Friedreich ataxia.
    Wilson RB
    J Child Neurol; 2012 Sep; 27(9):1212-6. PubMed ID: 22791549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondrial dysfunction in friedreich's ataxia.
    Lodi R; Taylor DJ; Schapira AH
    Biol Signals Recept; 2001; 10(3-4):263-70. PubMed ID: 11351132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in the molecular pathogenesis of Friedreich ataxia.
    Puccio H; Koenig M
    Hum Mol Genet; 2000 Apr; 9(6):887-92. PubMed ID: 10767311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iron regulatory protein 1 sustains mitochondrial iron loading and function in frataxin deficiency.
    Martelli A; Schmucker S; Reutenauer L; Mathieu JRR; Peyssonnaux C; Karim Z; Puy H; Galy B; Hentze MW; Puccio H
    Cell Metab; 2015 Feb; 21(2):311-323. PubMed ID: 25651183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidative stress induces mitochondrial fragmentation in frataxin-deficient cells.
    Lefevre S; Sliwa D; Rustin P; Camadro JM; Santos R
    Biochem Biophys Res Commun; 2012 Feb; 418(2):336-41. PubMed ID: 22274609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting the gene in Friedreich ataxia.
    Hebert MD
    Biochimie; 2008 Aug; 90(8):1131-9. PubMed ID: 18206656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptide SS-31 upregulates frataxin expression and improves the quality of mitochondria: implications in the treatment of Friedreich ataxia.
    Zhao H; Li H; Hao S; Chen J; Wu J; Song C; Zhang M; Qiao T; Li K
    Sci Rep; 2017 Aug; 7(1):9840. PubMed ID: 28852135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in mitochondrial glutathione levels and protein thiol oxidation in ∆yfh1 yeast cells and the lymphoblasts of patients with Friedreich's ataxia.
    Bulteau AL; Planamente S; Jornea L; Dur A; Lesuisse E; Camadro JM; Auchère F
    Biochim Biophys Acta; 2012 Feb; 1822(2):212-25. PubMed ID: 22200491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deciphering the cause of Friedreich ataxia.
    Koenig M; Mandel JL
    Curr Opin Neurobiol; 1997 Oct; 7(5):689-94. PubMed ID: 9384553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PPAR gamma agonist leriglitazone improves frataxin-loss impairments in cellular and animal models of Friedreich Ataxia.
    Rodríguez-Pascau L; Britti E; Calap-Quintana P; Dong YN; Vergara C; Delaspre F; Medina-Carbonero M; Tamarit J; Pallardó FV; Gonzalez-Cabo P; Ros J; Lynch DR; Martinell M; Pizcueta P
    Neurobiol Dis; 2021 Jan; 148():105162. PubMed ID: 33171227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assembly and iron-binding properties of human frataxin, the protein deficient in Friedreich ataxia.
    Cavadini P; O'Neill HA; Benada O; Isaya G
    Hum Mol Genet; 2002 Feb; 11(3):217-27. PubMed ID: 11823441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mice harboring the FXN I151F pathological point mutation present decreased frataxin levels, a Friedreich ataxia-like phenotype, and mitochondrial alterations.
    Medina-Carbonero M; Sanz-Alcázar A; Britti E; Delaspre F; Cabiscol E; Ros J; Tamarit J
    Cell Mol Life Sci; 2022 Jan; 79(2):74. PubMed ID: 35038030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Iron Pathophysiology in Friedreich's Ataxia.
    Li K
    Adv Exp Med Biol; 2019; 1173():125-143. PubMed ID: 31456208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glutathione-dependent redox status of frataxin-deficient cells in a yeast model of Friedreich's ataxia.
    Auchère F; Santos R; Planamente S; Lesuisse E; Camadro JM
    Hum Mol Genet; 2008 Sep; 17(18):2790-802. PubMed ID: 18562474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The expression of human mitochondrial ferritin rescues respiratory function in frataxin-deficient yeast.
    Campanella A; Isaya G; O'Neill HA; Santambrogio P; Cozzi A; Arosio P; Levi S
    Hum Mol Genet; 2004 Oct; 13(19):2279-88. PubMed ID: 15282205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The structure and function of frataxin.
    Bencze KZ; Kondapalli KC; Cook JD; McMahon S; Millán-Pacheco C; Pastor N; Stemmler TL
    Crit Rev Biochem Mol Biol; 2006; 41(5):269-91. PubMed ID: 16911956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.